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                        Abstract 
Background :  To determine the efficacy of 
vitamin C in reducing duration of severe pneumonia 
in children 
Methods: In this descriptive study children 
suffering from pneumonia , under age 5 were 
enrolled.. In vitamin C group (n=111), patient 
received 200mg of vitamin C once daily and in other 
group 111 children received placebo drops which 
matched exactly in color and taste. Clinical progress 
of both groups was taken thrice daily in terms of 
oxygen saturation, respiratory rate and chest in 
drawing. 
Results: Among 222 children, majority (61.71%) 
were male and 85(38.28%) were female. Majority 
(58.55%) were infants, 29.72% were between 1-3 years 
and 11.71% were between 4-5 years(15.14+7.76 
months). Oxygen saturation was improved in < 01 
day (p=0.003) and respiratory rate was improved in < 
04 days (p=0.03) in vitamin C group. No statistically 
significant difference was found in chest in drawing. 
Conclusion: Vitamin C is effective in reducing 
duration of severe pneumonia in children less than 
five years of age.  
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Introduction 
      Pneumonia is a disease causing inflammation of 
parenchyma of lungs. It is caused by variety of 
organisms including bacteria, viruses, fungi, or 
parasites.1 According to UNICEF and WHO, 
pneumonia is the 2nd most common cause of under 5 
mortality after neonatal deaths accounting for 19% of 
deaths and 95% of all new pneumonia cases in 
children occur in developing countries with highest 
number of cases in India followed by China, Pakistan 
and Bangladesh. 2 , 3 Pakistan is the 4th  largest 
contributor with 7 million cases per year in children 
less than 5 years of age out of which over 92,000 
children die each year.2 
     Risk factors for developing pneumonia include lack 
of breast feeding, top feeding, malnutrition, low 
immunization coverage, low socioeconomic status and 
deficiency of vitamin C and zinc.3 In malnourished 
children vitamin C levels in body are negligible and 
decrease further during infections. It acts as major 
biological antioxidant and protects against reactive 
oxygen species generated during inflammatory 
response and reduces duration and severity of 
infections.4 Amongst Millennium Development Goal 
the 4th goal focuses on reducing under 5 mortality to 
two third by 2015 and it requires urgent actions to 
reduce childhood pneumonia deaths. 2 ,5  
     Vitamin C is an important antioxidant acting as a 
reducing agent to reverse oxidation in liquids.6,7 When 
there are more free radicals in the human body than 
antioxidants, the condition is called oxidative stress 
and has an impact on cardiovascular disease, 
hypertension, chronic inflammatory diseases, diabetes 
as well as on critically ill patients and individuals with 
severe burns.8,9 Beneficial effects of vitamin C against 
respiratory tract infections (RTIs) are caused by its 
antioxidant properties. In RTIs, neutrophils release 
large amounts of oxidizing compounds that are toxic 
to other cells. Activation of neutrophils promotes an 
efficient consumption of extracellular vitamin C, 
which suggests that high concentration of vitamin C 
may provide protection against the harmful effects of 
oxidants released.10-12 
    Vitamin C has special importance in malnourished 
children in whom vitamin C and zinc level are very 
low and immune system becomes very weak. 
Antibiotics have a role in bacterial infection but not in 
viral infections which are usually self limited by 
body’s immune response. So if body immune response 
is weak, viral infection can become very serious and 
life threatening. Currently there is no role of antiviral 
therapy in pneumonia.To strengthen the immune 
response, vitamin C and zinc are the suggested 
therapeutic candidates in these patients.13 Various 
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studies have proved that zinc and vitamin C have 
synergistic effect against pneumonia. Hence it is 
appropriate and beneficial to give combination of zinc 
and vitamin C to children during treatment of 
pneumonia along with antibiotic and 
bronchodilator.4.14 Various studies have been done on 
vitamin C in the prophylaxis and treatment of 
respiratory tract infections in adults, however research 
on Vitamin C for children is rare. Two studies have 
been found addressing this issue one in Bangladesh 
and other in United States of America.15, 16, 17  
 
Patients  and Methods 
    This study was conducted at Pediatric Department, 
Islamic International Medical College-Trust, (IIMC-T), 
Railway Hospital, Rawalpindi, from 1st April 2010 to 
31st March 2011.           Children aged 2 month to 5 
years suffering from severe pneumonia admitted in 
pediatric ward of Railway Hospital were included in 
the study. Children having severe neutropenia 
(Absolute neutrophil count <500/mm3), children with 
concomitant non-pulmonary infections, lack of 
improvement with treatment within 48 hours and 
children referred from other hospitals who had 
already got some treatment were excluded from the 
study. 
     In vitamin C group (n=111), children received 
200mg of vitamin C drops (2 ml = 4 dropper mixed in 
milk or water) once daily. In other group (n=111) 
children received placebo drops (consisted of sodium 
citrate along with coloring agent mixed in water), 
which matched exactly with vitamin C drops in color 
and taste. Rest of the treatment (IV Amoxicillin and 
supportive treatment) was same in both groups. 
Clinical progress of both the groups was taken thrice 
daily in terms of oxygen saturation, respiratory rate 
and chest indrawing. The number of days taken by 
severe pneumonia to improve was recorded . Criteria 
for improvement was respiratory rate less than 
50/min (in an infant 2 months up to 12 months and 
less than 40/min( in a child 1 year up to 5 years), no 
chest Indrawing and Oxygen saturation >95% on room 
air.  Chi square test was used to compare the efficacy 
of drugs in both groups. p-value less than 0.05 was 
considered significant. 
 
Results 
     In vitamin C group 73(65.76%) were male and 
38(34.23%) were female.In placebo group 64 (57.65%) 
were male and 47(42.34%) were female. Majority were 
less than one year of age (Table 1) and majority had 
weight between 5th to 25th centile (Table 2).In Vitamin 
C group significant difference was observed between 
number of days consumed to show improvement in 
respiratory rate (3.61+ 1.50 mean + SD) and oxygen 
saturation (1.03+ 0.16 mean + SD) as compared to 
placebo group where days taken by respiratory rate 
and oxygen saturation to improve were  (4.04 + 1.62 
mean + SD) and (1.14+ 1.0 mean + SD) respectively. 
No significant difference was detected between the 
two groups for chest indrawing (Table 3).   
Table 1: Distribution of age in study groups 
Age Vitamin C Placebo Total 
Less than 1 Year 59 71 130 
1-3 Years 38 28 66 
4-5 Years 14 12 26 
 
Table2: Distribution of weight by centile  
Centile Vitamin C Placebo Total 
Less than 5th 
centile 
32 27 59 
Between 5th and 
25th centile 
47 69 116 
Between 50th and 
95th centile 
28 14 42 
Above 95th centile 3 2 5 
 
Table 3: Comparison between vitamin C  
and placebo group 
Indicators  
Vitamin C 
(n=111) 
freq (% ) 
Placebo 
(n=111) 
freq ( % ) 
P-
value 
Respiratory Rate 
to improve  
< 04 days 
Yes 84(76) 69(62) 
0.030* 
No 27(24) 42(38) 
Chest in drawing 
to improve  
< 02 days 
Yes 70(63) 59(53) 
0.135 
No 41(37) 52(47) 
Oxygen Saturation 
to improve    < 01 
day 
Yes 108(97) 96(86) 
0.003** 
No 03(03) 15(14) 
*Statistically significant at <0.05;** Statistically significant at <0.01 
 
Discussion 
    Few studies have been carried out regarding role of 
vitamin C in pneumonia. In these studies 
improvement was monitored in terms of respiratory 
rate and chest indrawing but oxygen saturation was 
not considered in any of these studies.In our study, 
oxygen saturation improved first followed by chest 
indrawing and fast breathing with mean + SD of 
1.03+0.16,  2.23+1.11 and 3.61+1.50 respectively in 
vitamin C group as compared to 1.14 + 0.34(P 0.003)=, 
2.54 +1.14 (p = 0.038) and 4.04 +1.62 (p = 0.44) days in 
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placebo group. These results are comparable to the 
study done in Rangpur Bangladesh where chest 
indrawing improved in 3.0 days in vitamin C group as 
compared to 3.5 days in control group and fast 
breathing improved in 4 days in vitamin C group as 
compared to 4.5 days in control group. 16  
     In a study conducted in Israel, total no. of  days 
(mean + SD) of acute respiratory tract infections were 
2.1+2.9 in vitamin C group as compared to 5.4+4.4 in 
placebo group. 17 These results are comparable to our 
study but showed much greater improvement as 
compared to present study and that conducted in 
Rangpur, Bangladesh. One study conducted in Soviet 
Union in adults suffering from pneumonia found a 
dose dependant reduction in time to recovery with 2 
doses of vitamin C.15In study done in United Kingdom 
on elderly patients suffering from pneumonia, low 
mortality and good progress in the vitamin C group 
was noted as compared to those in placebo group. 18  
     In present study vitamin C levels were not done, 
due to non-availability. Double blinding of study was 
not done which could be the source of bias in this 
study. We didn’t group the children having bacterial 
or viral pneumonia. Further studies should be done 
separately in bacterial and viral pneumonia to see in 
which group vitamin C is more effective and also 
separate studies should be done in children having 
normal level of vitamin C and vitamin C deficient 
children to see in which group it is more effective. We 
exclude the children less than 2 months of age and 
with neutropenia.  
Conclusion 
1.Vitamin C is effective in reducing duration of severe 
pneumonia in children less than five years of age.  
2.Vitamin C should be included in treatment protocol 
of children with pneumonia so that mortality and 
morbidity can be reduced cost effectively. 
3. It is important  to find out the response of vitamin C 
in pneumonias, in relation to different age groups and 
etiologies. 
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